Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Aug 10, 2021 5:14am
163 Views
Post# 33676933

RE:RE:RE:Remote training and installation

RE:RE:RE:Remote training and installation
GrahamB wrote:
leonenoel wrote:

Hi Jennifer,

The CEO said during the June 10 webinar that GE's revenue model is to place the machines for free and collect pay per use fees from insurance reimbursements.  He also specifically said that the buyout agreement is for 80-100 machines sold or placed.

GE will send the Ventripoint equipment "ipad on a stick" as an upgrade to to their ultrasound machines already installed in hospitals and clinics.

GE just needs to call the places with their machines and say "we have an essential free upgrade, it will take 15 minutes to install and learn how to use it. When can bring it over?"

 


 

 

Jennifer you indicate that :"He also specifically said that the buyout agreement is for 80-100 machines sold or placed."

You are stating that a buyout agreement has been established.
This is material and would , to my understanding of securities regulations, warrant a SEDAR filing.

I follow SEDAR filings closely and can not verify your statement.

Can you clarify?
G



At about 52 minutes the possibility of a buyout is discussed if sales/revenue materializes, as I understand it.
There is no mention of an agreement to sell the company as you have stated above.
'If anyone can provide proof of an agreement, please do so.
Otherwise such statements are promotional and misleading.
'Promotional videos with speculative statements don't cut it.

<< Previous
Bullboard Posts
Next >>